Cancer

Prospective, Non-Interventional Study of Disease Progression and Treatment of Patients with Polycythemia Vera in United States Academic or Community Clinical Practices

This is a prospective, observational study of standard medical care for Polycythemia Vera (PV). The purpose of the study is to find out more information about people with PV, follow the course of the disease in these people, and find out how the disease and standard medical care affect the daily life of people being treated for PV. The use of healthcare resources will also be studied.

Primary disease category:

Secondary disease category(ies):

Cancer, Leukemia & Lymphoma

Testing the effect of metformin on breast cancer risk features

The purpose of this study is to see if taking metfomin can affect some of the risk factors associated with breast cancer, such as breast density, certain proteins and hormones, certain metabolites produced in the body, body weight, waist and hip sizes.

Primary disease category:

Secondary disease category(ies):

Breast Cancer, Prevention

Study for treatment of castration resistant metastatic prostate cancer

Primary disease category:

Secondary disease category(ies):

Prostate Cancer

Study for treatment of leukemia in older adults

Primary disease category:

Secondary disease category(ies):

Leukemia & Lymphoma

Study for treatment of myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML)

Primary disease category:

Secondary disease category(ies):

Leukemia & Lymphoma, Myeloma

Study for treatment of colorectal cancer

Primary disease category:

Secondary disease category(ies):

Colorectal Cancer

Symptoms In Ovarian Cancer (PRECISION study)

Primary disease category:

Study for treatment of untreated Acute Myeloid Leukemia (AML)

This study is open to adults age 18 to 60 years.

Primary disease category:

Secondary disease category(ies):

Leukemia & Lymphoma

Study for treatment of newly diagnosed high risk multiple myeloma (HRMM)

Primary disease category:

Secondary disease category(ies):

Study for treatment of relapsed or refractory multiple myeloma

Primary disease category:

Secondary disease category(ies):

Pages